Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,7813,800 of 20,252 grants

Completed OTHER RESEARCH-RELATED
Functional and Pharmacologic Investigation of the NUP98 Fusion Oncoprotein Interactome
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2023 – 2025

PROJECT SUMMARY Chromosomal translocations involving Nucleoporin 98 (NUP98) are observed in approximately 5% of pediatric acute myeloid leukemia (AML) and are associated with resis...

$1.41M
USD
Completed NON-SBIR/STTR RPGS
Emerging role of tumor-derived exosomes in immune modulation and breast cancer health disparity.
NATIONAL CANCER INSTITUTE University of North Texas Hlth Sci Ctr United States 2023 – 2025

Project Abstract Triple-negative breast cancer (TNBC) is an aggressive and invasive breast cancer subtype, accounting for 10-15% of breast cancer diagnoses. TNBC affects African-Am...

$1.73M
USD
Completed NON-SBIR/STTR RPGS
Transcriptional Activation of p62 by the master antioxidant NRF2 in EBV latency
NATIONAL CANCER INSTITUTE East Tennessee State University United States 2023 – 2024

Project Summary EBV infection is associated with a panel of diseases and cancers, and serves as a fascinating paradigm for the study of host-virus interactions. Oxidative stress is...

$824K
USD
Completed NON-SBIR/STTR RPGS
The role of PRMT5 in preventing intra-chromosomal deletions in cancer cells
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2025

Project Summary/Abstract PRMT5 is an arginine methyltransferase with key roles in cancer. The gene has pleiotropic functions ranging from gene regulation and development to modulat...

$787.5K
USD
Completed NON-SBIR/STTR RPGS
Discovering the Timing and Origins of Bone and Soft Tissue Cancers
NATIONAL CANCER INSTITUTE Hospital for Sick Chldrn (Toronto Canada 2023 – 2025

SUMMARY Sarcomas are cancers of the bone and connective tissue that affect a higher proportion of children than adults. Many childhood sarcomas are difficult to diagnose, which can...

$1.27M
USD
Completed NON-SBIR/STTR RPGS
A Pilot Feasibility Study of an Intervention to Decrease Overtreatment of Low-risk Thyroid Cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2025

PROJECT SUMMARY Nearly 90% of patients with low-risk papillary thyroid cancer undergo total thyroidectomy, the treatment option with the greatest morbidity, even though less invasi...

$840.2K
USD
Active NON-SBIR/STTR RPGS
The biological effect and the mode of action of the CXCL7-CXCL12 chemokine heterodimer
NATIONAL CANCER INSTITUTE University of North Carolina Charlotte United States 2023 – 2026

ABSTRACT Chemokines are essential in health and disease such as infections, autoimmune diseases, atherosclerosis, HIV/AIDS, and cancer. Many chemokines engage in heterophilic inter...

$4.62M
USD
Active NON-SBIR/STTR RPGS
Early response to radiotherapy and immunotherapy in rectal cancer: an integrated molecular, cellular, and spatial approach
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

Project Abstract With increased incidence in young populations and ~65% three-year survival of high-risk locally advanced rec- tal cancer, innovative approaches to improve outcomes...

$6.57M
USD
Active NON-SBIR/STTR RPGS
Exploring the Role of Nitrogen Metabolism in Cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2030

PROJECT SUMMARY/ABSTRACT There has been a renewed interest in how oncogenic driver mutations and tumor suppressor losses contribute to cancer-associated alterations in cellular met...

$9.26M
USD
Active NON-SBIR/STTR RPGS
Using implantable microdevices for deep phenotyping of multiple drug responses in brain tumor patients
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2028

Gliomas are a particularly aggressive type of brain cancer with poor prognosis that affect about 20,000 newly diagnosed patients in the US annually. There is high interest in ident...

$7.47M
USD
Completed NON-SBIR/STTR RPGS
The role of the intestinal microbiome in cancer immunotherapy
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2023

ABSTRACT The gut microbiota consists of a community of diverse microbes and has many effects on human (patho)physiology. Microbiome composition has been associated with many diseas...

$3.04M
USD
Completed SBIR-STTR RPGS
Regulation of RNA Decapping and Degradation: A novel approach to prostate cancer therapy
NATIONAL CANCER INSTITUTE Vortex Biotechnology Corporation United States 2023 – 2025

Prostate cancer (PCa) is the most frequent killer of men with over 34,000 deaths per year. If PCa is not cured by initial definitive surgery and/or radiation and spreads to lymph n...

$3.97M
USD
Completed NON-SBIR/STTR RPGS
Reducing the chasm in behavioral health care for older adults with cancer: Development of the Center for Implementation Research in Cancer in Later Life (CIRCL)
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2025

PROJECT SUMMARY Older adults with cancer (OACs) comprise a large and growing proportion of cancer patients and survivors. Many OACs have unmet behavioral health needs with signific...

$2.01M
USD
Active NON-SBIR/STTR RPGS
LncRNA EPIC1 induces immunotherapy resistance by activating EZH2 in breast cancer
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2023 – 2028

Summary:On July 26, 2021, the FDA approved the anti-PD1 immunotherapy pembrolizumab (Keytruda®, Merck) for triple negative breast cancer (TNBC) patients. Although significant progr...

$4.06M
USD
Active NON-SBIR/STTR RPGS
Targeting PLK1 signaling for the treatment of fibrolamellar carcinoma
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

PROJECT SUMMARY Fibrolamellar carcinoma (FLC) is a childhood liver cancer with a high case mortality rate. Patients with FLC typically present with advanced disease, as there are n...

$4.92M
USD
Active NON-SBIR/STTR RPGS
Therapy-induced cognitive impairment in a rat model of prostate cancer
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2023 – 2028

Androgen deprivation therapy (ADT) is a mainstay of prostate cancer treatment. However, ADT has adverse effects, including cognitive impairment that compromises quality of life for...

$4.12M
USD
Completed NON-SBIR/STTR RPGS
Circadian Clock and Myc-dependent Regulation of Cellular Transformation
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2023 – 2025

The supplement instructions for PAR-22-114 state: “At a minimum, the Research Strategy section should be completed and must include a summary or abstract of the funded parent award...

$1.35M
USD
Active NON-SBIR/STTR RPGS
Optimizing Treatment of Prostate Cancer in Men living with HIV
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2023 – 2028

SUMMARY Cancer is a leading cause of morbidity and mortality among aging people with HIV (PWH) and prostate cancer is now one of the most common cancers among PWH. Despite this, pr...

$7.2M
USD
Completed NON-SBIR/STTR RPGS
Elucidating the mechanism of Ga13 mediated tumor suppression in pancreatic cancer
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2023 – 2024

RESEARCH SUMMARY The heterotrimeric G proteins transduce signals from the G protein-coupled receptors (GPCRs), the largest class of cell surface proteins that regulate a wide varie...

$4.23M
USD
Active NON-SBIR/STTR RPGS
Consequences of retrotransposition on genome integrity
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

Project SummaryTransposable elements are a major source of human genetic variation and also contribute to human diseases by causing somatic mutations. The activity of transposition...

$7.71M
USD